A carregar...
Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering—A Cross-Sectional Analysis
BACKGROUND. Rare cancers are a heterogeneous group of conditions with highly unmet medical needs. Although infrequent in individuals, rare cancers affect millions of people who deserve effective treatments. Therefore, we systematically analyzed the impact of the U.S. Orphan Drug Act of 1983 on deliv...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4828121/ https://ncbi.nlm.nih.gov/pubmed/27022038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0397 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|